ENTX
Price
$1.98
Change
-$0.02 (-1.00%)
Updated
Jun 27 closing price
Capitalization
89.99M
40 days until earnings call
ENVB
Price
$1.24
Change
-$0.03 (-2.36%)
Updated
Jun 27 closing price
Capitalization
3.09M
Interact to see
Advertisement

ENTX vs ENVB

Header iconENTX vs ENVB Comparison
Open Charts ENTX vs ENVBBanner chart's image
Entera Bio
Price$1.98
Change-$0.02 (-1.00%)
Volume$15.7K
Capitalization89.99M
Enveric Biosciences
Price$1.24
Change-$0.03 (-2.36%)
Volume$468.82K
Capitalization3.09M
ENTX vs ENVB Comparison Chart in %
Loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTX vs. ENVB commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Buy and ENVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ENTX: $1.98 vs. ENVB: $1.24)
Brand notoriety: ENTX and ENVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 35% vs. ENVB: 176%
Market capitalization -- ENTX: $89.99M vs. ENVB: $3.06M
ENTX [@Biotechnology] is valued at $89.99M. ENVB’s [@Biotechnology] market capitalization is $3.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileENVB’s FA Score has 1 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • ENVB’s FA Score: 1 green, 4 red.
According to our system of comparison, ENVB is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 3 TA indicator(s) are bullish while ENVB’s TA Score has 3 bullish TA indicator(s).

  • ENTX’s TA Score: 3 bullish, 6 bearish.
  • ENVB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ENVB is a better buy in the short-term than ENTX.

Price Growth

ENTX (@Biotechnology) experienced а -0.01% price change this week, while ENVB (@Biotechnology) price change was -2.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ENTX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTX($90M) has a higher market cap than ENVB($3.09M). ENTX YTD gains are higher at: -6.608 vs. ENVB (-76.935). ENVB has higher annual earnings (EBITDA): -9.01M vs. ENTX (-10.05M). ENTX has more cash in the bank: 12.6M vs. ENVB (4.29M). ENVB has less debt than ENTX: ENVB (0) vs ENTX (220K). ENTX has higher revenues than ENVB: ENTX (223K) vs ENVB (0).
ENTXENVBENTX / ENVB
Capitalization90M3.09M2,913%
EBITDA-10.05M-9.01M111%
Gain YTD-6.608-76.9359%
P/E RatioN/AN/A-
Revenue223K0-
Total Cash12.6M4.29M293%
Total Debt220K0-
FUNDAMENTALS RATINGS
ENTX vs ENVB: Fundamental Ratings
ENTX
ENVB
OUTLOOK RATING
1..100
791
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5065
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (16) in the Electronics Or Appliances industry is somewhat better than the same rating for ENTX (71) in the Pharmaceuticals Major industry. This means that ENVB’s stock grew somewhat faster than ENTX’s over the last 12 months.

ENTX's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that ENTX’s stock grew similarly to ENVB’s over the last 12 months.

ENTX's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ENVB (99) in the Electronics Or Appliances industry. This means that ENTX’s stock grew similarly to ENVB’s over the last 12 months.

ENTX's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as ENVB (65) in the Electronics Or Appliances industry. This means that ENTX’s stock grew similarly to ENVB’s over the last 12 months.

ENTX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that ENTX’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTXENVB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.220.32
+1.07%
Smith & Nephew plc
THFF54.210.21
+0.39%
First Financial Corp
SIMA10.440.02
+0.19%
SIM Acquisition Corp I
LUCK9.310.01
+0.11%
Lucky Strike Entertainment Corporation
SKIL15.90-0.86
-5.13%
Skillsoft Corp

ENTX and

Correlation & Price change

A.I.dvisor tells us that ENTX and STOK have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and STOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
-1.00%
STOK - ENTX
33%
Poorly correlated
-1.77%
DNLI - ENTX
31%
Poorly correlated
-2.69%
IMNM - ENTX
30%
Poorly correlated
-0.23%
ORKA - ENTX
28%
Poorly correlated
-4.73%
PCVX - ENTX
28%
Poorly correlated
-0.91%
More

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with VANI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-2.36%
VANI - ENVB
42%
Loosely correlated
+0.76%
CDXS - ENVB
27%
Poorly correlated
-5.16%
VTVT - ENVB
26%
Poorly correlated
-6.82%
ENTX - ENVB
25%
Poorly correlated
-1.00%
KPTI - ENVB
25%
Poorly correlated
-2.23%
More